A18.54 Tuberculous iridocyclitis

Name of the Condition

• Tuberculous iridocyclitis
• ICD Code: A18.54

Summary

Tuberculous iridocyclitis is a rare form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects the iris and ciliary body of the eye. This condition occurs when TB bacteria spread from a primary site, typically the lungs, to the eye via the bloodstream or lymphatic system. It causes inflammation of the anterior uvea, which may lead to vision impairment if not promptly diagnosed and treated.

Causes

Tuberculous iridocyclitis is caused by the dissemination of Mycobacterium tuberculosis from an existing infection, usually pulmonary tuberculosis. The bacteria can travel to the iris and ciliary body during active disease or reactivation of latent TB. Direct inoculation is rare but possible in certain cases.

Risk Factors

• Immunocompromised states, such as HIV/AIDS or chronic immunosuppressive therapy.
• History of untreated or inadequately treated tuberculosis.
• Close contact with individuals who have active TB.
• Living in or traveling to regions with high TB prevalence.
• Underlying conditions like diabetes or malnutrition.

Symptoms

• Redness and swelling in the eye.
• Decreased vision or blurred vision.
• Eye pain and sensitivity to light (photophobia).
• Floaters or seeing spots.
• Discharge or tearing.

Diagnosis

Diagnosis involves a comprehensive eye examination, including slit-lamp evaluation to assess the anterior segment, measurement of intraocular pressure, and assessment of visual acuity. Laboratory tests, such as acid-fast bacilli staining or PCR, may be performed on ocular samples to detect Mycobacterium tuberculosis. Imaging studies or systemic evaluations may be used to identify the primary TB infection site.

Treatment Options

Treatment typically involves a multidrug regimen for tuberculosis, including isoniazid, rifampin, ethambutol, and pyrazinamide, tailored to the patient's condition and drug susceptibility. Corticosteroids may be used to reduce inflammation, but their use requires careful monitoring to avoid complications. Adjunctive therapies, such as cycloplegics, may be prescribed to relieve pain and prevent synechiae formation.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for tuberculous iridocyclitis is generally favorable, though vision loss may occur if the condition is severe or delayed. Regular follow-up is essential to monitor treatment response, manage side effects, and prevent recurrence. Long-term surveillance may be necessary to detect late complications or reactivation.

Complications

• Permanent vision loss due to inflammation or scarring.
• Cataract formation.
• Glaucoma from elevated intraocular pressure.
• Synechiae (adhesions) between the iris and lens.
• Retinal detachment in severe cases.

Lifestyle & Prevention

• Maintain good overall health to support immune function.
• Follow prescribed TB treatment regimens strictly.
• Avoid exposure to individuals with active TB in high-prevalence areas.
• Practice good hygiene and avoid sharing personal items that may transmit infection.
• Seek early medical care for any eye symptoms to prevent progression.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, severe eye pain, increased redness, or sensitivity to light. Prompt evaluation is critical to prevent permanent damage and ensure timely treatment.

Tips for Medical Coders

Document the specific site (iris and ciliary body) and confirm the diagnosis of tuberculous iridocyclitis. Ensure clinical documentation supports the use of code A18.54, as it is a distinct subcategory of tuberculosis of the eye. Verify that the condition is not better classified under a more specific code or a different chapter of the ICD-10-CM.